Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-018798
Filing Date
2025-10-21
Accepted
2025-10-21 16:49:28
Documents
10
Period of Report
2025-10-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm PRE 14A 425147
2 EX-1 ex1.htm EX-1 1522
3 EX-2 ex2.htm EX-2 12751
4 EX-3 ex3.htm EX-3 13043
5 EX-4 ex4.htm EX-4 12991
6 EX-5 ex5.htm EX-5 12857
7 EX-7 ex7.htm EX-7 12047
8 GRAPHIC formpre14a_001.jpg GRAPHIC 4043
9 GRAPHIC ex1_001.jpg GRAPHIC 361806
10 GRAPHIC ex1_002.jpg GRAPHIC 224500
  Complete submission text file 0001493152-25-018798.txt   1304920
Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

EIN.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-21617 | Film No.: 251407676
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)